Estrogen positive breast cancer recurrence during tamoxifen therapy: microdissected tumor
Expression profiling of microdissected estrogen positive primary breast cancer tumors from 60 patients. Patients later treated with tamoxifen for 5 years, and tumors grouped according to whether cancer recurred. Results identify markers of disease-free survival that include HOXB13 and IL17BR.
Cancer Type: Breast Cancer
GPL: 1223
Number of Genes with Data: 827
Number Observations: 60
Number Outputs: 1
Imbalanced Ratio: 0.875
Default Task: Classification